Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-2063PMID 16540640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 isoforms can regulate p53 transcriptional activity.

  2005cited by this paper
• Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters

  2005cited by this paper
• p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors.

  2005cited by this paper
• The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality

  2005cited by this paper
• Defective apoptosis and B‐cell lymphomas in mice with p53 point mutation at Ser 23

  2004influential reference
• Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene.

  2004cited by this paper
• Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice

  2004cited by this paper
• Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• p53 has a direct apoptogenic role at the mitochondria.

  2003cited by this paper
• PUMA mediates the apoptotic response to p53 in colorectal cancer cells

  2003cited by this paper
• Decision making by p53: life, death and cancer

  2003cited by this paper
• mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation

  2003cited by this paper
• p53 and apoptosis: it's not just in the nucleus anymore.

  2003cited by this paper
• Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

  2003cited by this paper
• The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

  2003cited by this paper
• p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene.

  2002cited by this paper
• Dissecting p53 tumor suppressor functions in vivo.

  2002cited by this paper
• Loss of p53 and centrosome hyperamplification

  2002cited by this paper
• Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.

  2002cited by this paper
• Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription

  2002cited by this paper
• 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally

  2002cited by this paper
• Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool

  2001cited by this paper
• PUMA induces the rapid apoptosis of colorectal cancer cells.

  2001cited by this paper
• UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin.

  2001cited by this paper
• Regulation of p53 function.

  2001cited by this paper
• Estimation of relative mRNA content by filter hybridization to a polyuridylic probe.

  2000cited by this paper
• Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2

  1999cited by this paper
• Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

  1999cited by this paper
• Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.

  1999cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis

  1994cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994influential reference
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• p53 is required for radiation-induced apoptosis in mouse thymocytes

  1993cited by this paper
• What the papers say: The p53‐mdm2 autoregulatory feedback loop: A paradigm for the regulation of growth control by p53?

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.

  1988cited by this paper

• Translating p53-based therapies for cancer into the clinic

  2024cites this paper
• Long non-coding RNA GNAS-AS1 knockdown inhibits proliferation and epithelial–mesenchymal transition of lung adenocarcinoma cells via the microRNA-433-3p/Rab3A axis

  2023cites this paper
• Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule

  2021cites this paper
• Anti-Cancer Mechanisms of Taurine in Human Nasopharyngeal Carcinoma Cells.

  2019cites this paper
• Novel allosteric mechanism of p53 activation by small molecules for targeted anticancer therapy

  2018cites this paper
• Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.

  2017cites this paper
• Senescence, Apoptosis, and Cancer

  2017cites this paper
• p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.

  2013cites this paper
• p53 in the Clinics

  2013cites this paper
• Distinct target genes and effector processes appear to be critical for p53-activated responses to acute DNA damage versus p53-mediated tumour suppression

  2013cites this paper
• Humanised Mouse Models: Targeting the Murine p53 Locus with Human Sequences

  2013cites this paper
• Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation

  2012cites this paper
• Molecular and Cellular Pathobiology Cancer Research Mouse Models for the p 53 R 72 P Polymorphism Mimic Human Phenotypes

  2010cites this paper
• Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock‐in (Hupki) mouse model

  2010cites this paper
• How to become immortal: let MEFs count the ways

  2010cites this paper
• TP53 mutations in human cancers: origins, consequences, and clinical use.

  2010cites this paper
• Regulation of apoptosis by Caspases under oxidative stress conditions in mice testicular cells: in vitro molecular mechanism

  2009cites this paper
• TP 53 Mutations in Human Cancers : Origins , Consequences , and Clinical Use

  2009cites this paper
• p53 polymorphisms: cancer implications

  2009cites this paper
• Selecting the Right Targets for Cancer Therapy

  2008cites this paper
• Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.

  2008cites this paper
• TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

  2007cites this paper
• The codon 72 polymorphism-specific effects of human p53 are absent in mouse cells: implications on generation of mouse models

  2007influential citation